Multiple Sclerosis

November 10, 2017

Relapsing MS Patients Being Recruited to Global Phase 3 Trial of Ponesimod Plus Tecfidera

New study of an MS medication is recruiting for patients. Actelion is recruiting about 600 relapsing multiple sclerosis (MS) patients to a Phase 3 trial testing the […]
February 7, 2017

‘Stunning breakthrough’ helping to rapidly identify types of MS

New diagnostic tests for multiple sclerosis are in the works. Patients with multiple sclerosis will soon have access to a new test which can tell them […]
April 27, 2016

Study suggests remarkable approach to MS treatment

Researchers are exploring new treatment options for multiple sclerosis, specifically therapy that is more effective and less toxic. Multiple sclerosis (MS) is an autoimmune inflammatory disorder […]
March 22, 2016

MS and Sleep Disorders: What’s Next?

Recently, in my blog No Rest for Multiple Sclerosis, the prevalence of sleep disorders in those with multiple sclerosis was explored. Research in the Journal of […]
January 21, 2016

Overcoming MS: One Step at a Time

Multiple sclerosis is an abnormal immune response of body’s nervous system that causes it to attack the central nervous system, which includes the brain, spinal cord, […]
January 15, 2016

The MS Game Changer

A new medication for multiple sclerosis made waves when research about its effectiveness debuted at the Congress of the European Committee for Treatment and Research in […]
January 15, 2016

MS Changes With the Seasons

Multiple sclerosis (MS), for most people, has an unpredictable way it changes over time. While MS is generally progressive, meaning it gets worse with time, there […]